Our data indicated a close association between VEGFR2 and GRP78/BiP and PPC metastasis, tumor invasiveness, and patient survival; however, whether their targeting would increase chemotherapeutic efficacy remains unclear. This evidence concerns the gene HSPA5 and neoplasm.